A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies

SIMPLE SUMMARY: One of the main challenges faced by cancer immunotherapy is the emergence of resistance against monotherapies, mediated by several immune escape mechanisms, which are able to impair therapy outcomes. Here, we investigated the biological properties of two novel bispecific constructs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Manna, Lorenzo, Rapuano Lembo, Rosa, Yoshioka, Asami, Nakamura, Koji, Passariello, Margherita, De Lorenzo, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670465/
https://www.ncbi.nlm.nih.gov/pubmed/38001604
http://dx.doi.org/10.3390/cancers15225345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670465/
https://www.ncbi.nlm.nih.gov/pubmed/38001604
http://dx.doi.org/10.3390/cancers15225345

Ejemplares similares